Abstract
It will also be critical to continue assessing co-administration of other vaccines in the future, since COVID-19 vaccine boosters are likely to be part of routine immunization in the future, at least in selected vulnerable population. It will be particularly critical to assess the safety of simultaneous immunization with vaccines that are equally reactogenic than the current COVID-19 vaccines, such as adjuvanted vaccines. Eventually, the development of combination vaccines in adults, following the model of pediatric vaccines, is also urgently needed to optimize vaccine coverage and alleviate any remaining concerns on vaccine co-administration.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
